Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[High-risk group--lung cancer].

H Niitani, M Hino

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |September 1, 1987
    PubMed
    Summary

    Lung cancer risk factors like air pollution, occupation, and smoking are reviewed. Identifying high-risk groups is crucial for understanding lung cancer development and improving patient care.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cross-resistance to antineoplastic agents in a human small-cell lung-cancer subline resistant to okadaic Acid.

    Oncology reports·2011
    Same author

    Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer.

    British journal of cancer·2003
    Same author

    The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancer.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2002
    Same author

    A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.

    International journal of clinical oncology·2002
    Same author

    Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.

    International journal of clinical oncology·2001
    Same author

    Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer.

    British journal of cancer·2001

    Area of Science:

    • Environmental Health
    • Oncology
    • Pulmonology

    Background:

    • Lung cancer arises from exposure to numerous external factors.
    • Understanding lung cancer's origins and identifying at-risk individuals is vital for diagnosis and treatment.

    Purpose of the Study:

    • To review established risk factors for lung cancer.
    • To identify high-risk groups associated with lung cancer development.

    Main Methods:

    • Literature review of established lung cancer risk factors.
    • Analysis of environmental, occupational, and lifestyle-related factors.

    Main Results:

    • Key risk factors identified include air pollution, occupational exposures, and smoking habits.
    • Individuals with pre-existing lung diseases are also considered a high-risk group.

    Conclusions:

    • Multiple factors contribute to lung cancer carcinogenesis.
    • Recognition of these risk factors and high-risk groups aids in lung cancer prevention and management.